Dr. Howard Smith Oncall

Vidcast:  https://www.instagram.com/p/DOwaN4mDH8S/The new Moderna mRNA CoVid vaccine is named mNEXSPIKE; their original CoVid vaccine was named SPIKEVAX.  This second generation mRNA CoVid vaccine yields a stronger and longer-lasting antibody response to the virus.  By targeting specific viral spike proteins rather than all proteins contained in the spike itself, the robust antibody response lasts 6 months or longer rather than the usual 4 to 5 month duration.Due to its novelty, mNEXSPIKE has been approved only for adults 65 years of age and older as well as those 12 years through 64 years of age with complicating medical issues that place them at high risk for severe COVID-19.Not all pharmacies are stocking mNEXSPIKE, so, if you are eligible, check with yours.The second Moderna CoVid vaccine is the updated SPIKEVAX.  This vaccine as well as the mNEXSPIKE produce antibodies against the JN.1 subvariant of the Omicron CoVid variant.This vaccine is approved for all children 6 months through 17 years of age. It i